Astellas Pharma has 16 carcinostatic drugs and 7 companion diagnostic reagents under development

Astellas Pharma R&D Meeting, July 11, 2012

Astellas Pharma has 16 carcinostatic drugs and 7 companion diagnostic reagents under development
Scroll to top